Francesc C. Casas

Salvage radiotherapy after cryotherapy in prostate cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 22, 2025

CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models.

Journal: Drug delivery and translational research

Published: June 12, 2025

CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models.

Journal: Drug delivery and translational research

Published: June 12, 2025

Corrigendum to "Biological effective dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy" [Radiother. Oncol. 183 (2023) 109552].

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 23, 2023

Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases.

Journal: Frontiers in immunology

Published: June 07, 2023

Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 15, 2022

Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: September 20, 2022

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.

Journal: The Lancet. Oncology

Published: December 15, 2021

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations.

Journal: World journal of clinical oncology

Published: March 26, 2021

Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 15, 2021

Salvage radiotherapy after cryotherapy in prostate cancer.

Salvage radiotherapy after cryotherapy in prostate cancer.

CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models.

CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models.

CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models.

CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models.

Corrigendum to "Biological effective dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy" [Radiother. Oncol. 183 (2023) 109552].

Corrigendum to "Biological effective dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy" [Radiother. Oncol. 183 (2023) 109552].

Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases.

Clinical outcomes and timing on the combination of focal radiation therapy and immunotherapy for the treatment of brain metastases.

Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.

Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.

Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy.

Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy.

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations.

Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations.

Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.

Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.

GOECP/SEOR radiotherapy guidelines for small-cell lung cancer.

GOECP/SEOR radiotherapy guidelines for small-cell lung cancer.

Is invasive mediastinal staging necessary in intermediate risk patients with negative PET/CT?

Is invasive mediastinal staging necessary in intermediate risk patients with negative PET/CT?